Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …

Bronchiectasis is a disease of renewed interest in light of an increase in prevalence and
increasing burden on international healthcare systems. There are no licensed therapies …

Background Bronchiectasis is a heterogeneous, neglected disease with few multicentre
studies exploring the causes, severity, microbiology, and treatment of the disease across …

Background Bronchiectasis is a common but neglected chronic lung disease. Most
epidemiological data are limited to cohorts from Europe and the USA, with few data from low …

Bronchiectasis refers to both a clinical disease and a radiological appearance that has
multiple causes and can be associated with a range of conditions. Disease heterogeneity …

Background Identifying risk factors for poor outcomes can help with risk stratification and
targeting of treatment. Risk factors for mortality and exacerbations have been identified in …

Bronchiectasis is a major health problem that is increasing in prevalence and burden
globally [1, 2]. The impact of bronchiectasis on patients and the healthcare system is …

While identifying the underlying aetiology is a key part of bronchiectasis management, the
prevalence and impact of identifying the aetiologies on clinical management remain unclear …

Rationale: Testing for underlying etiology is a key part of bronchiectasis management, but it
is unclear whether the same extent of testing is required across the spectrum of disease …

Bronchiectasis (BE) is a chronic and progressive respiratory disease with multiple possible
causes [1, 2]. Many require a specific therapy and thus, a systematic aetiologic evaluation is …